drugset / Trial / NCT01843504
Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy
RandomizedParallel-groupSingle-blindTreatment
Summary
The goal of this study is to find an effective treatment for chronic patellar tendinopathy (PT). Investigators will conduct a 32-week randomized controlled clinical trial to determine whether platelet rich plasma (PRP) injections improve disease-specific clinical outcomes with correlation to a new method of ultrasound (US) imaging assessment called Acoustoelastography (AE). Positive findings of PRP compared to control would suggest future larger scale studies to help establish an optimal protocol for the nonsurgical management of PT.
Timeline
- Start
- 2014-01
- Primary completion
- 2024-02-29
- Completion
- 2024-02-29
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Platelet Rich Plasma | Other / unclassified | 5 ml | Other |